SCHEMBL6319172

SCHEMBL6319172

Cc1c(-c2coc3ccccc23)c(Cl)c2c(nc3ccccn32)c1C#N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.35
ALDH1A1 P00352 10/20 0.34
GAA P10253 9/20 0.34
GLA P06280 8/20 0.34
S1PR4 O95977 4/20 0.34
S1PR1 P21453 4/20 0.34
HSD17B10 Q99714 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33
MAPK10 P53779 1/20 0.33
HPGD P15428 5/20 0.32
CASP1 P29466 2/20 0.32
RECQL P46063 2/20 0.32
CASP7 P55210 2/20 0.32
BLM P54132 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
S1PR2 O95136 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6319505 0.81 KDM4E (0.34) KDM4EALDH1A1GAAGLAS1PR4
SCHEMBL6310367 0.81 HTT (0.43) KDM4EALDH1A1HSD17B10NPC1RAB9A
SCHEMBL6311468 0.81 HPGD (0.45) KDM4EALDH1A1GAAHSD17B10MEN1
SCHEMBL6319340 0.80 KDM4E (0.35) KDM4EALDH1A1GAAGLAS1PR4
SCHEMBL6312786 0.79 KDM4E (0.44) KDM4EALDH1A1GAAGLAS1PR4
SCHEMBL6313201 0.78 MCHR1 (0.35) MAPK10
SCHEMBL6311042 0.76 KDM4E (0.45) KDM4EALDH1A1GAAHSD17B10MEN1
SCHEMBL6309849 0.76 KDM4E (0.41) KDM4EALDH1A1GAAGLAS1PR4
SCHEMBL6310683 0.76 KDM4E (0.36) KDM4EALDH1A1GAAGLAS1PR4
SCHEMBL6312626 0.75 PIK3CD (0.45) KDM4EALDH1A1GAAGLAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KDM4E 3360/4885ALDH1A1 2550/4885GAA 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.